Weekly IDEXX Laboratories, Inc. (NASDAQ:IDXX) Ratings on Jun 26, 2018

June 26, 2018 - By Sarah Harris

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Corporate Logo
Big Money Sentiment decreased to 0.76 in Q1 2018. It has change of 0.05, from 2017Q4’s 0.81. The ratio worsened due to IDEXX Laboratories, Inc. positioning: 37 sold and 232 reduced. 83 funds amassed positions and 122 increased positions. Investors holded 72.13 million in 2017Q4 but now own 72.24 million shares or 0.16% more.
Pub Sector Pension Invest Board accumulated 4,829 shs. Gsa Cap Ptnrs Ltd Liability Partnership has invested 0.04% in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Apg Asset Mgmt Nv accumulated 17,300 shs. Spark Invest Lc reported 1,400 shs or 0.02% of all its holdings. 2,059 are owned by Colony Group Ltd Limited Liability Company. The Illinois-based Citadel Ltd Company has invested 0.01% in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Royal Natl Bank Of Canada has invested 0.01% of its capital in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Hills Bancorp stated it has 0.08% of its capital in IDEXX Laboratories, Inc. (NASDAQ:IDXX). 3,440 are held by Portland Glob Advsr Ltd Company. Cubist Systematic Strategies Llc holds 0.12% or 11,125 shs in its capital. Tekla Cap Mngmt Ltd Liability accumulated 153,076 shs. Denali Ltd Liability Corp holds 0.02% in IDEXX Laboratories, Inc. (NASDAQ:IDXX) or 600 shs. State Of Wisconsin Board accumulated 105,829 shs. Great West Life Assurance Can holds 0.03% of its capital in IDEXX Laboratories, Inc. (NASDAQ:IDXX) for 61,444 shs. 3,621 are held by Scotia Cap Inc.

IDEXX Laboratories, Inc. had 9 selling transactions and 2 insider purchases since January 9, 2018. This’s net activity of $23.87 million. END WILLIAM T also sold $737,939 worth of IDEXX Laboratories, Inc. (NASDAQ:IDXX) shs. AYERS JONATHAN W had sold 54,000 shs worth $8.96 million. The insider Kingsley Lawrence D bought 1,000 shs worth $178,045. $179,580 worth of stock was bought by Claflin Bruce L. on Wednesday, February 7. On Tuesday, May 29 a trade for 1,626 shs valued at $332,306 was made by TWIGGE GIOVANI. Another trade for 2,974 shs valued at $565,232 was sold by JUNIUS DANIEL M.

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Ratings Coverage

In total 6 analysts cover IDEXX Laboratories (NASDAQ:IDXX). “Buy” rating has 6, “Sell” are 0, while 0 are “Hold”. 100% are bullish. 9 are the (NASDAQ:IDXX)’s analyst reports since January 16, 2018 according to StockzIntelligence Inc. In Thursday, June 21 report Credit Suisse maintained it with “Outperform” rating and $231 target. On Monday, May 7 the stock of IDEXX Laboratories, Inc. (NASDAQ:IDXX) earned “Buy” rating by Canaccord Genuity. On Monday, May 7 the firm has “Buy” rating given by Stifel Nicolaus. The stock rating was maintained by Stifel Nicolaus with “Buy” on Thursday, February 1. In Monday, January 29 report Canaccord Genuity maintained the stock with “Buy” rating. In Friday, June 1 report Credit Suisse maintained the stock with “Outperform” rating. In Friday, February 2 report Bank of America maintained it with “Buy” rating and $220 target. Listed here are IDEXX Laboratories, Inc. (NASDAQ:IDXX) PTs and latest ratings.

21/06/2018 Broker: Credit Suisse Old Rating: Outperform New Rating: Outperform Old Target: $228 New Target: $231 Maintain
01/06/2018 Broker: Credit Suisse Old Rating: Outperform New Rating: Outperform Old Target: $209 New Target: $228 Maintain
07/05/2018 Broker: Canaccord Genuity Rating: Buy New Target: $225.0000 Maintain
07/05/2018 Broker: Stifel Nicolaus Old Rating: Buy New Rating: Buy Old Target: $215 New Target: $225 Maintain
02/02/2018 Broker: Bank of America Old Rating: Buy New Rating: Buy Old Target: $200 New Target: $220 Maintain
01/02/2018 Broker: Stifel Nicolaus Rating: Buy New Target: $215.0 Maintain
01/02/2018 Broker: Piper Jaffray Rating: Buy New Target: $211.0
29/01/2018 Broker: Canaccord Genuity Rating: Buy New Target: $210.0 Maintain
16/01/2018 Broker: PiperJaffray Rating: Overweight New Target: $200 Initiates Coverage On

Ticker’s shares touched $217.86 during the last trading session after 0.17% change.Currently IDEXX Laboratories, Inc. is uptrending after 21.68% change in last June 26, 2017. IDXX has 192,156 shares volume. IDXX outperformed by 9.11% the S&P500.

IDEXX Laboratories, Inc., together with its subsidiaries, develops, makes, and distributes services and products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide.The firm is valued at $18.92 billion. It operates through Companion Animal Group; Water Quality Products; Livestock, Poultry and Dairy; and Other divisions.The P/E ratio is 68.53. The firm provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assays; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community.

Another two news for IDEXX Laboratories, Inc. (NASDAQ:IDXX) were briefly brought out by: Investorplace.com on June 12, 2018 with title “The Top 20 Stocks of 2018”. The other Fool.com‘s article was titled “The 6 Stocks on the MFM Team’s Radar This Week” and brought out on June 19, 2018.

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.